Works matching IS 11738804 AND DT 2021 AND VI 35 AND IP 5
Results: 7
Comparative Risk of Arterial Thromboembolic Events Between Aflibercept and Ranibizumab in Patients with Maculopathy: A Population-Based Retrospective Cohort Study.
- Published in:
- BioDrugs, 2021, v. 35, n. 5, p. 579, doi. 10.1007/s40259-021-00497-4
- By:
- Publication type:
- Article
Targeting Leukocyte Trafficking in Inflammatory Bowel Disease.
- Published in:
- BioDrugs, 2021, v. 35, n. 5, p. 473, doi. 10.1007/s40259-021-00496-5
- By:
- Publication type:
- Article
Vaccine-Associated Enhanced Viral Disease: Implications for Viral Vaccine Development.
- Published in:
- BioDrugs, 2021, v. 35, n. 5, p. 505, doi. 10.1007/s40259-021-00495-6
- By:
- Publication type:
- Article
Cryopreservation of NK and T Cells Without DMSO for Adoptive Cell-Based Immunotherapy.
- Published in:
- BioDrugs, 2021, v. 35, n. 5, p. 529, doi. 10.1007/s40259-021-00494-7
- By:
- Publication type:
- Article
Is There Any Research Evidence Beyond Surveys and Opinion Polls on Automatic Substitution of Biological Medicines? A Systematic Review.
- Published in:
- BioDrugs, 2021, v. 35, n. 5, p. 547, doi. 10.1007/s40259-021-00493-8
- By:
- Publication type:
- Article
Analytical Similarity Assessment of ABP 959 in Comparison with Eculizumab Reference Product.
- Published in:
- BioDrugs, 2021, v. 35, n. 5, p. 563, doi. 10.1007/s40259-021-00492-9
- By:
- Publication type:
- Article
Advances in Immunotherapy for Diffuse Large B Cell Lymphoma.
- Published in:
- BioDrugs, 2021, v. 35, n. 5, p. 517, doi. 10.1007/s40259-021-00491-w
- By:
- Publication type:
- Article